Vicarious Surgical (NYSE:RBOT) Trading Up 3.8%

Vicarious Surgical Inc (NYSE:RBOT)’s share price was up 3.8% on Thursday . The company traded as high as $0.29 and last traded at $0.29. Approximately 211,198 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 648,866 shares. The stock had previously closed at $0.28.

Wall Street Analysts Forecast Growth

Separately, Piper Sandler reduced their price target on Vicarious Surgical from $1.50 to $1.00 and set a “neutral” rating on the stock in a report on Tuesday, March 5th.

Vicarious Surgical Price Performance

The company has a market cap of $50.53 million, a price-to-earnings ratio of -0.59 and a beta of 1.18. The business’s fifty day moving average price is $0.34 and its 200 day moving average price is $0.38.

Vicarious Surgical (NYSE:RBOT) last announced its earnings results on Monday, March 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.05. During the same period in the prior year, the business earned ($0.16) EPS. As a group, equities research analysts anticipate that Vicarious Surgical Inc will post -0.39 EPS for the current year.

Institutional Trading of Vicarious Surgical

Institutional investors and hedge funds have recently bought and sold shares of the company. Barclays PLC boosted its position in shares of Vicarious Surgical by 541.6% during the 4th quarter. Barclays PLC now owns 14,840 shares of the company’s stock valued at $30,000 after acquiring an additional 12,527 shares during the last quarter. Riverwater Partners LLC lifted its position in Vicarious Surgical by 89.9% during the third quarter. Riverwater Partners LLC now owns 52,895 shares of the company’s stock valued at $31,000 after purchasing an additional 25,042 shares during the last quarter. SRS Capital Advisors Inc. grew its stake in Vicarious Surgical by 215.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 87,905 shares of the company’s stock worth $32,000 after buying an additional 60,000 shares in the last quarter. Verition Fund Management LLC bought a new position in shares of Vicarious Surgical in the 2nd quarter worth $36,000. Finally, Citigroup Inc. raised its position in shares of Vicarious Surgical by 1,758.2% during the 2nd quarter. Citigroup Inc. now owns 20,868 shares of the company’s stock valued at $38,000 after buying an additional 19,745 shares in the last quarter. 47.27% of the stock is currently owned by hedge funds and other institutional investors.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.